RAPP
Rapport Therapeutics
RAPP
RAPP
122 hedge funds and large institutions have $1.46B invested in Rapport Therapeutics in 2025 Q3 according to their latest regulatory filings, with 51 funds opening new positions, 36 increasing their positions, 20 reducing their positions, and 9 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
50% more funds holding in top 10
Funds holding in top 10: 4 → 6 (+2)
29.54% more ownership
Funds ownership: 105.47% → 135.01% (+30%)
17% more call options, than puts
Call options by funds: $7.6M | Put options by funds: $6.49M
Holders
122
Holding in Top 10
6
Calls
$7.6M
Puts
$6.49M
Top Buyers
| 1 | +$42.8M | |
| 2 | +$35.3M | |
| 3 | +$29.6M | |
| 4 |
VPC
Vestal Point Capital
New York
|
+$28.2M |
| 5 |
PCH
Polar Capital Holdings
London,
United Kingdom
|
+$27.9M |
Top Sellers
| 1 | -$21.2M | |
| 2 | -$12.6M | |
| 3 | -$8.88M | |
| 4 |
SAM
Sectoral Asset Management
Montreal,
Quebec, Canada
|
-$4.05M |
| 5 |
LGM
Logos Global Management
San Francisco,
California
|
-$2.38M |
